|
|
Other links at Articles > Diabetes and Endocrinology |
| 3. |
First-Line EGFR Inhibition May Benefit Selected Lung Cancer Patients
|
|
|
There is "strong evidence" that selected groups of patients with advanced non-small cell lung cancer (NSCLC) may benefit from first-line therapy with an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, according to the authors of a report in the March issue of the Journal of Thoracic Oncology. Reuters Health Information
|
| 5. |
Fish Oil Supplements Cut Adiposity in Type 2 Diabetics
|
|
|
Two months of daily fish oil supplements reduces adiposity and atherogenic markers in women with type 2 diabetes, French researchers report in the American Journal of Clinical Nutrition for December. Reuters Health Information
|
|
|